The Effect of Magnesium Sulphate on the Time Course of Rocuronium Induced Neuromuscular Block

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Neuromuscular Blockade
Interventions
DRUG

Physiologic saline

Intravenous infusion of the study solution, 1 ml per kg bodyweight, corresponding to MgSO4 60 mg kg-1 in the magnesium group and 1 ml per kg physiological saline. The infusion will be given with during 15 minutes.

DRUG

Magnesium sulphate

Intravenous infusion of the study solution, 1 ml per kg bodyweight, corresponding to MgSO4 60 mg kg-1 in the magnesium group. The infusion will be given during 15 minutes.

Trial Locations (1)

1211

University Hospital of Geneva, Anesthesia Department, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT00405977 - The Effect of Magnesium Sulphate on the Time Course of Rocuronium Induced Neuromuscular Block | Biotech Hunter | Biotech Hunter